Tornier HRS Max Parts Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Tornier, Inc. is recalling 233 units of incorrectly labeled medical devices due to incompatibility with the intended system, affecting distribution across multiple U.S. states.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 23, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Tornier, Inc. is recalling certain medical devices because they were incorrectly labeled as Tornier HRS Max products. These parts are compatible only with the Tornier HRS system and not with the Tornier HRS Max system.
Which Products Are Affected
The affected products are:
- TORNIER HRS Max Tuberosity Body Lat Coat, Small, Cat. No. ARS1041101
- TORNIER HRS Max Tuberosity Body No Coat, Small, Cat. No. ARS1041102
- TORNIER HRS Max Trial, Cat. No. ARS10252 A total of 233 units are involved. The products include UDI-DI (GTIN) codes: 00840338603623 for the first product with lot numbers AZ0124352, AZ0224352, AZ0324352, AZ0424352, and AZ0524352; 00840338603630 for the second product with lot numbers AZ0624352, AZ0724352, AZ0824352, AZ0924352, and AZ1024352; and 00840338604033 for the third product with lot numbers AZ0124351, AZ0224351, AZ0524351, AZ0724351, and AZ0924351. Distribution occurred nationwide in the United States, specifically in the states of AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KY, MA, MN, MO, NC, NE, NH, NJ, NV, NY, OH, OK, OR, PA, SD, TN, TX, UT, VA, WA, and WI. The official recall number is Z-1769-2026.
What You Should Do
Consumers who have these products should check if they possess the affected items based on the provided catalog numbers and lot numbers, and follow the initial firm notification, which was issued via letter.
Why This Matters
This recall highlights potential risks associated with incorrect labeling of medical devices, which could lead to improper use and affect patient safety in the United States.
Source
From FDA recall Z-1769-2026, attributed to the U.S. Food and Drug Administration (FDA).
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,685 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 23, 2026.
Frequently Asked Questions
Common questions about this FDA recall.